Press News

2013.05.31 Notice of Third-party Allotment of No. 8 to No. 11 Issues of Stock Acquisition Rights

The Board of Directors of tella, Inc. (the “Company”) approved a resolution on May 31, 2013 to issue the No. 8 to No. 11 issues of stock acquisition rights using a third-party allotment. Notice of Third-party Allotment of No. 8 to No. 11 Issues of Stock Acquisition Rights

• Notice regarding the Establishment of a Subsidiary New Entry into ‘Imaging CRO’ Clinical Trial Support Business Using the Latest Imaging Technology and Concentrating in New Anti-cancer Treatments
• Development of New Immunotherapy for Autoimmune Diseases and Allergies by Using a New Technology That Utilizes the Effects of Dendritic Cells (DC)～tella receives exclusive right for use of technology concerning regulatory DC～